Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | PRKDC | P78527 | 3/20 | 0.39 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | TNKS | O95271 | 1/20 | 0.32 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.32 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.31 |
| ▸ | BRD4 | O60885 | 1/20 | 0.31 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.31 |
| ▸ | PIK3CB | P42338 | 1/20 | 0.31 |
| ▸ | MTOR | P42345 | 1/20 | 0.31 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.31 |
| ▸ | DNPH1 | O43598 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29319333 | 0.93 | ALOX5 (0.49) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL20243813 | 0.83 | PARP14 (0.44) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL22360201 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL15179434 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL12175700 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL24609434 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL21347677 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL21249227 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL24609435 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 | |
| SCHEMBL18596991 | 0.82 | ALOX5 (0.64) | ALOX5PRKDCPARP14TNKSTNKS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10374171-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2019-08-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10374171-B2 | Organic electroluminescent materials and devices | TPR, EED, TEAD2 | ALOX5 1768/4885PRKDC 3673/4885PARP14 1751/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.